Molecular biology, Progenitor cell, Cellular differentiation, Cell culture and Immunology are his primary areas of study. The various areas that he examines in his Molecular biology study include After treatment, Gene rearrangement, Chromosomal translocation and Carcinogen. The study incorporates disciplines such as Haematopoiesis and Growth factor in addition to Progenitor cell.
His Haematopoiesis study incorporates themes from Myeloid and Bone marrow. His Cellular differentiation research is multidisciplinary, incorporating elements of Stem cell factor and Cell biology. His work deals with themes such as microRNA and Cell growth, which intersect with Stem cell factor.
Mauro Valtieri focuses on Haematopoiesis, Molecular biology, Cell biology, Progenitor cell and Immunology. The concepts of his Haematopoiesis study are interwoven with issues in CD34, Growth factor, Cellular differentiation and Bone marrow. His study in Molecular biology is interdisciplinary in nature, drawing from both Interleukin 3, Endocrinology, Gene expression, Internal medicine and microRNA.
His biological study spans a wide range of topics, including Proto-Oncogene Proteins c-myb, Cell culture and Erythropoietin receptor. His work in the fields of Cell culture, such as Transfection, overlaps with other areas such as Expression vector. His Immunology research includes themes of Interleukin 12, Cancer research and Tumor suppressor gene.
His main research concerns Cell biology, Mesenchymal stem cell, Bone marrow, Molecular biology and microRNA. His research integrates issues of Phenotype, Cell, Genetics and In vitro growth in his study of Cell biology. His research investigates the link between Bone marrow and topics such as Stromal cell that cross with problems in Regenerative medicine.
Mauro Valtieri interconnects mir-223, Cell culture and Chromosomal translocation in the investigation of issues within Molecular biology. The Cell culture study combines topics in areas such as Stem cell factor, In vitro, Cell growth and Cellular differentiation. His work is dedicated to discovering how Transfection, Progenitor cell are connected with Haematopoiesis and other disciplines.
His primary scientific interests are in microRNA, Bone marrow, Cell growth, Cellular differentiation and Immunology. Much of his study explores microRNA relationship to Cancer research. His Bone marrow research incorporates elements of Stromal cell, Regenerative medicine and Cell biology.
His Cell growth research integrates issues from Cell culture, Transfection, Progenitor cell, Stem cell factor and Molecular biology. As part of his studies on Cellular differentiation, Mauro Valtieri frequently links adjacent subjects like Chondrogenesis. Mauro Valtieri focuses mostly in the field of Immunology, narrowing it down to topics relating to Mesenchymal stem cell and, in certain cases, Exosome, Paracrine signalling, Molecular medicine and Microvesicles.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation
Nadia Felli;Laura Fontana;Elvira Pelosi;Rosanna Botta.
Proceedings of the National Academy of Sciences of the United States of America (2005)
KDR Receptor: A Key Marker Defining Hematopoietic Stem Cells
B. L. Ziegler;M. Valtieri;M. Valtieri;G. Almeida Porada;R. De Maria;R. De Maria.
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
Paolo Neviani;Ramasamy Santhanam;Rossana Trotta;Mario Notari.
Cancer Cell (2005)
High-Efficiency Gene Transfer and Selection of Human Hematopoietic Progenitor Cells with a Hybrid EBV/Retroviral Vector Expressing the Green Fluorescence Protein
Francesco Grignani;Todd Kinsella;Amedea Mencarelli;Mauro Valtieri.
Cancer Research (1998)
Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line.
M. Valtieri;D. J. Tweardy;D. Caracciolo;Keith R Johnson.
Journal of Immunology (1987)
Identification of the hemangioblast in postnatal life.
Elvira Pelosi;Mauro Valtieri;Simona Coppola;Rosanna Botta.
Multi-Level Effects of flt3 Ligand on Human Hematopoiesis: Expansion of Putative Stem Cells and Proliferation of Granulomonocytic Progenitors/Monocytic Precursors
M. Gabbianelli;E. Pelosi;E. Montesoro;M. Valtieri.
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells.
Antonio Sorrentino;Manuela Ferracin;Germana Castelli;Mauro Biffoni.
Experimental Hematology (2008)
Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines
B Lange;M Valtieri;D Santoli;D Caracciolo.
Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging.
Bruno Calabretta;Robert B. Sims;Mauro Valtieri;Daniele Caracciolo.
Proceedings of the National Academy of Sciences of the United States of America (1991)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: